DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1DR REDDYS LABS SA
02 1ACTAVIS LABS FL INC
03 1AMNEAL PHARMS
04 2APOTEX INC
05 8ASTRAZENECA
06 1ASTRAZENECA AB
07 1AUROBINDO PHARMA USA
08 1BARR LABS DIV TEVA
09 1CALLIDITAS
10 2CHEPLAPHARM
11 3CIPLA
12 1EUGIA PHARMA
13 2IMPAX LABS INC
14 3J AND J CONSUMER INC
15 1LUPIN
16 3MYLAN
17 1NATCO
18 2NEPHRON
19 1PADAGIS ISRAEL
20 1PADAGIS US
21 1RISING
22 2SALIX
23 3SANDOZ
24 1SCIECURE PHARMA INC
25 3SUN PHARM
26 2SUN PHARM INDS INC
27 1TAKEDA PHARMS USA
28 2TEVA PHARMS
29 1TEVA PHARMS USA
30 1ZYDUS PHARMS
01 2AEROSOL, FOAM;RECTAL
02 5AEROSOL, METERED;INHALATION
03 1AEROSOL, METERED;NASAL
04 12CAPSULE, DELAYED RELEASE;ORAL
05 4POWDER, METERED;INHALATION
06 5SPRAY, METERED;NASAL
07 21SUSPENSION;INHALATION
08 1SUSPENSION;ORAL
09 3TABLET, EXTENDED RELEASE;ORAL
01 9DISCN
02 2OTC
03 40RX
04 3Blank
01 2BREYNA
02 1BREZTRI AEROSPHERE
03 31BUDESONIDE
04 1ENTOCORT EC
05 1EOHILIA
06 2ORTIKOS
07 2PULMICORT
08 2PULMICORT FLEXHALER
09 3PULMICORT RESPULES
10 3RHINOCORT
11 1RHINOCORT ALLERGY
12 2SYMBICORT
13 1TARPEYO
14 2UCERIS
01 35No
02 16Yes
03 3Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
Brand Name : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 3MG
Approval Date : 2016-04-08
Application Number : 206623
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
